Published in Proc Natl Acad Sci U S A on November 18, 2013
Distribution of circular proteins in plants: large-scale mapping of cyclotides in the Violaceae. Front Plant Sci (2015) 0.81
Distinct profiling of antimicrobial peptide families. Bioinformatics (2014) 0.80
Plant cystine-knot peptides: pharmacological perspectives. Br J Clin Pharmacol (2016) 0.80
Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A (2016) 0.80
Immunosuppressive peptides and their therapeutic applications. Drug Discov Today (2013) 0.80
Peptidomics of Circular Cysteine-Rich Plant Peptides: Analysis of the Diversity of Cyclotides from Viola tricolor by Transcriptome and Proteome Mining. J Proteome Res (2015) 0.79
Inhibition of Human Prolyl Oligopeptidase Activity by the Cyclotide Psysol 2 Isolated from Psychotria solitudinum. J Nat Prod (2015) 0.77
From ethnopharmacology to drug design. Commun Integr Biol (2014) 0.76
Cyclotide structure-activity relationships: qualitative and quantitative approaches linking cytotoxic and anthelmintic activity to the clustering of physicochemical forces. PLoS One (2014) 0.76
Two Blast-independent tools, CyPerl and CyExcel, for harvesting hundreds of novel cyclotides and analogues from plant genomes and protein databases. Planta (2014) 0.75
Myometrial contractility influences oxytocin receptor (OXTR) expression in term trophoblast cells obtained from the maternal surface of the human placenta. BMC Pregnancy Childbirth (2015) 0.75
Continuous and selective measurement of oxytocin and vasopressin using boron-doped diamond electrodes. Sci Rep (2016) 0.75
An exploration of village-level uterotonic practices in Fenerive-Est, Madagascar. BMC Pregnancy Childbirth (2016) 0.75
Chemical and biological production of cyclotides. Adv Bot Res (2016) 0.75
Development of a human vasopressin V1a-receptor antagonist from an evolutionary-related insect neuropeptide. Sci Rep (2017) 0.75
Cyclotides Isolated from an Ipecac Root Extract Antagonize the Corticotropin Releasing Factor Type 1 Receptor. Front Pharmacol (2017) 0.75
[MUW resarcher of the month]. Wien Klin Wochenschr (2014) 0.75
Lybatides from Lycium barbarum Contain An Unusual Cystine-stapled Helical Peptide Scaffold. Sci Rep (2017) 0.75
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol (1973) 47.81
Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry (2004) 2.32
Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. J Mol Biol (1999) 2.29
Chemistry. Seamless proteins tie up their loose ends. Science (2006) 1.66
Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol (2012) 1.63
Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry (1995) 1.61
Telomerase immortalization of human myometrial cells. Biol Reprod (2002) 1.48
The oxytocin receptor. Trends Endocrinol Metab (2003) 1.47
Distribution and evolution of circular miniproteins in flowering plants. Plant Cell (2008) 1.37
Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design. Biochem J (2006) 1.35
Plant cyclotides disrupt epithelial cells in the midgut of lepidopteran larvae. Proc Natl Acad Sci U S A (2008) 1.28
Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds. Blood (2011) 1.24
Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment. Angew Chem Int Ed Engl (2012) 1.24
Physiological pathways and molecular mechanisms regulating uterine contractility. Hum Reprod Update (2010) 1.23
On the effect of a polypeptide isolated from "Kalata-Kalata" (Oldenlandia affinis DC) on the oestrogen dominated uterus. Acta Pharmacol Toxicol (Copenh) (1973) 1.23
Oldenlandia affinis (R&S) DC. A plant containing uteroactive peptides used in African traditional medicine. J Ethnopharmacol (2000) 1.23
Crystal structure analysis of deamino-oxytocin: conformational flexibility and receptor binding. Science (1986) 1.22
Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors. Curr Pharm Des (2010) 1.20
Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides. J Med Chem (2008) 1.17
Discovery of cyclotides in the fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins. ACS Chem Biol (2011) 1.14
Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity. J Med Chem (2012) 1.10
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. FEBS Lett (1996) 1.09
Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold. J Med Chem (2009) 1.06
Uterotonic plants and their bioactive constituents. Planta Med (2010) 1.04
Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptides. J Biol Chem (2008) 1.02
Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology. Crit Care (2003) 1.00
Cyclotides associate with leaf vasculature and are the products of a novel precursor in petunia (Solanaceae). J Biol Chem (2012) 1.00
Analysis and classification of circular proteins in CyBase. Biopolymers (2010) 1.00
Exploring bioactive peptides from natural sources for oxytocin and vasopressin drug discovery. Future Med Chem (2012) 1.00
Insights into the molecular evolution of oxytocin receptor ligand binding. Biochem Soc Trans (2013) 0.99
Mechanism of action of cytotoxic cyclotides: cycloviolacin O2 disrupts lipid membranes. J Nat Prod (2007) 0.98
Characterizing circular peptides in mixtures: sequence fragment assembly of cyclotides from a violet plant by MALDI-TOF/TOF mass spectrometry. Amino Acids (2012) 0.98
Cyclotides as a basis for drug design. Expert Opin Drug Discov (2012) 0.97
Do plant cyclotides have potential as immunosuppressant peptides? J Nat Prod (2012) 0.94
Phosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions. J Biol Chem (2012) 0.92
Discovery of linear cyclotides in monocot plant Panicum laxum of Poaceae family provides new insights into evolution and distribution of cyclotides in plants. J Biol Chem (2012) 0.91
Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1. J Biol Chem (2012) 0.91
Intracellular calcium stores and agonist-induced contractions in isolated human myometrium. Am J Obstet Gynecol (1999) 0.87
Uterine contractility of plants used to facilitate childbirth in Nigerian ethnomedicine. J Ethnopharmacol (2012) 0.86
The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats. J Neuroendocrinol (2012) 0.85
Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors. J Clin Endocrinol Metab (1990) 0.82
Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor. J Pharmacol Exp Ther (1996) 0.82
Importance of the cell membrane on the mechanism of action of cyclotides. ACS Chem Biol (2012) 0.81
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38
Nucleophilic catalysis of oxime ligation. Angew Chem Int Ed Engl (2006) 2.69
High-efficiency labeling of sialylated glycoproteins on living cells. Nat Methods (2009) 2.46
Nucleophilic catalysis of hydrazone formation and transimination: implications for dynamic covalent chemistry. J Am Chem Soc (2006) 2.45
Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology (2009) 2.44
Context-dependent contributions of backbone hydrogen bonding to beta-sheet folding energetics. Nature (2004) 2.44
Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry (2004) 2.32
Rapid oxime and hydrazone ligations with aromatic aldehydes for biomolecular labeling. Bioconjug Chem (2008) 2.25
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev (2003) 2.23
The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Mol Pharmacol (2005) 2.21
Increased generation of fibrocytes in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab (2009) 2.10
Leukemic challenge unmasks a requirement for PI3Kdelta in NK cell-mediated tumor surveillance. Blood (2008) 2.04
STAT1 acts as a tumor promoter for leukemia development. Cancer Cell (2006) 2.00
Protein disulfide isomerase: the structure of oxidative folding. Trends Biochem Sci (2006) 1.99
An efficient Fmoc-SPPS approach for the generation of thioester peptide precursors for use in native chemical ligation. Angew Chem Int Ed Engl (2008) 1.95
Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10. J Mol Biol (2006) 1.90
CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineering. Nucleic Acids Res (2007) 1.86
Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120. J Virol (2003) 1.84
An asparaginyl endopeptidase mediates in vivo protein backbone cyclization. J Biol Chem (2007) 1.77
Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol (2003) 1.75
Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody. J Virol (2006) 1.71
Laryngeal recurrent nerve injury in surgery for benign thyroid diseases: effect of nerve dissection and impact of individual surgeon in more than 27,000 nerves at risk. Ann Surg (2002) 1.69
A sulfilimine bond identified in collagen IV. Science (2009) 1.69
Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone. J Am Chem Soc (2003) 1.67
Processing of a 22 kDa precursor protein to produce the circular protein tricyclon A. Structure (2005) 1.67
Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates. Nat Mater (2006) 1.66
A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies. J Virol (2009) 1.63
Neuromonitoring in thyroid surgery: prospective evaluation of intraoperative electrophysiological responses for the prediction of recurrent laryngeal nerve injury. Ann Surg (2004) 1.61
Bisaryl hydrazones as exchangeable biocompatible linkers. Angew Chem Int Ed Engl (2010) 1.59
The N terminus of monoamine transporters is a lever required for the action of amphetamines. J Biol Chem (2010) 1.58
Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J Biol Chem (2006) 1.54
The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew Chem Int Ed Engl (2010) 1.54
Circular proteins--no end in sight. Trends Biochem Sci (2002) 1.53
Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. J Immunol (2003) 1.51
Structure of antibacterial peptide microcin J25: a 21-residue lariat protoknot. J Am Chem Soc (2003) 1.51
ConoServer, a database for conopeptide sequences and structures. Bioinformatics (2007) 1.50
Concentrative export from the endoplasmic reticulum of the gamma-aminobutyric acid transporter 1 requires binding to SEC24D. J Biol Chem (2007) 1.49
Escherichia coli-mediated impairment of ureteric contractility is uropathogenic E. coli specific. J Infect Dis (2012) 1.48
Twists, knots, and rings in proteins. Structural definition of the cyclotide framework. J Biol Chem (2002) 1.46
Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J Immunol (2008) 1.45
Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia? Biochem Pharmacol (2007) 1.44
Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. Nano Lett (2010) 1.42
Structures of the agouti signaling protein. J Mol Biol (2005) 1.42
Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol Pharmacol (2005) 1.42
Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci (2008) 1.41
The cyclotide family of circular miniproteins: nature's combinatorial peptide template. Biopolymers (2006) 1.39
The controlled display of biomolecules on nanoparticles: a challenge suited to bioorthogonal chemistry. Bioconjug Chem (2011) 1.39
Biosynthesis of circular proteins in plants. Plant J (2007) 1.39
Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell Signal (2002) 1.39
ConoServer: updated content, knowledge, and discovery tools in the conopeptide database. Nucleic Acids Res (2011) 1.38
Distribution and evolution of circular miniproteins in flowering plants. Plant Cell (2008) 1.37
A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell (2013) 1.37
Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII. Proc Natl Acad Sci U S A (2005) 1.37
The cyclotides and related macrocyclic peptides as scaffolds in drug design. Curr Opin Drug Discov Devel (2006) 1.37
Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes. Eur J Immunol (2002) 1.36
Functional analysis of the alpha-defensin disulfide array in mouse cryptdin-4. J Biol Chem (2004) 1.36
The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango. J Neurochem (2009) 1.36
Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design. Biochem J (2006) 1.35
Alpha-selenoconotoxins, a new class of potent alpha7 neuronal nicotinic receptor antagonists. J Biol Chem (2006) 1.34
Vimentin-positive, c-kit-negative interstitial cells in human and rat uterus: a role in pacemaking? Biol Reprod (2004) 1.34
Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. Bioconjug Chem (2006) 1.34
The cyclotides: novel macrocyclic peptides as scaffolds in drug design. Curr Opin Drug Discov Devel (2002) 1.33
Discovery, structure and biological activities of the cyclotides. Curr Protein Pept Sci (2004) 1.33
Cyclotides: a novel type of cytotoxic agents. Mol Cancer Ther (2002) 1.32
Albumins and their processing machinery are hijacked for cyclic peptides in sunflower. Nat Chem Biol (2011) 1.31
Cyclotides as templates in drug design. Drug Discov Today (2009) 1.31
Improved detection of DNA motifs using a self-organized clustering of familial binding profiles. Bioinformatics (2005) 1.29
Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation. J Neurosci (2008) 1.29
The synthesis, structural characterization, and receptor specificity of the alpha-conotoxin Vc1.1. J Biol Chem (2006) 1.28
Plant cyclotides disrupt epithelial cells in the midgut of lepidopteran larvae. Proc Natl Acad Sci U S A (2008) 1.28
Discovery, structure and biological activities of cyclotides. Adv Drug Deliv Rev (2009) 1.26
Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol (2002) 1.26
The three-dimensional solution structure of NaD1, a new floral defensin from Nicotiana alata and its application to a homology model of the crop defense protein alfAFP. J Mol Biol (2003) 1.26
Dysfunctional labor and myometrial lactic acidosis. Obstet Gynecol (2004) 1.26
Conopeptide characterization and classifications: an analysis using ConoServer. Toxicon (2010) 1.26
Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. ACS Nano (2011) 1.26
Toward assessing the position-dependent contributions of backbone hydrogen bonding to beta-sheet folding thermodynamics employing amide-to-ester perturbations. J Am Chem Soc (2004) 1.26
Depletion of membrane cholesterol eliminates the Ca2+-activated component of outward potassium current and decreases membrane capacitance in rat uterine myocytes. J Physiol (2007) 1.26
Extending synthetic access to proteins with a removable acyl transfer auxiliary. J Am Chem Soc (2002) 1.26
Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligomer formation in the human serotonin transporter. J Biol Chem (2003) 1.25
Isolation, solution structure, and insecticidal activity of kalata B2, a circular protein with a twist: do Möbius strips exist in nature? Biochemistry (2005) 1.24
Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds. Blood (2011) 1.24